About CHESS

  • Name: Liver Health Consortium in China
  • Established: 2016
  • Founder: Prof. Xiaolong Qi

Our Mission

To shape the practice of liver health.

Featured Events

  • Established a large community-based population cohort and completed screening of over 30,000 individuals
  • Established a world-class platform for clinical research and translational science in the field of liver health
  • Initiated 60+ international or domestic multi-center clinical research
  • Pioneered the Vasomics of the liver and extended it to the human vasculature
  • Founded programs for liver fibrosis screening in the general population in China
  • Promoted innovative technologies in 500+ hospitals across China and 30+ countries globally
  • Organized the Liver Health Development Forum (CHESS Annual Meeting)
  • Established Portal Hypertension Awareness and Prevention Day (December 6th) to promote early detection and standardized management
  • Launched the "Qinggan Scholar" program for young hepatology scholars aged 35 or younger worldwide

Official Journal — Portal Hypertension & Cirrhosis (PH&C)

Featured Publications

The International Chinese Young Scholars Alliance for the Study of the Liver: facilitating global collaboration
Li W, Cao Z, Yeo YH, et al.
2026 Nat Rev Gastroenterol Hepatol
Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study
Liu S, Liu X, Song J, et al.
2026 Lancet Gastroenterol Hepatol
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes
Chen Y, Dong B, Jin X, et al.
2026 Gut
Vasomics of the Liver
Wang C, Felli E, Fallowfield JA, et al.
2025 Gut
The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis
He X, Hu M, Xu Y, et al.
2025 Nat Med
Diagnostic accuracy of magnetically guided capsule endoscopy with a detachable string for detecting oesophagogastric varices in adults with cirrhosis: prospective multicentre study
Jiang X, Pan J, Xu Q, et al.
2024 BMJ
Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease
Qi X, Li J, Caussy C, et al.
2024 Hepatology
Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model
Wang C, Huang Y, Liu C, et al.
2023 Radiology
Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension
Qi X, An W, Liu F, et al.
2019 Radiology
Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension
Qi X, Berzigotti A, Cardenas A, et al.
2018 Lancet Gastroenterol Hepatol
CHESS WeChat Official Account

Scan to follow for updates from CHESS